MedPath

A randomized phase II study for reconstruction after distal gastrctomy (Billroth I versus Roux-en-Y method)

Phase 2
Conditions
Curative distal gastrectomy for gastric cancers
Registration Number
JPRN-UMIN000000878
Lead Sponsor
Clinical surgery research group/The supporting center for clinilcal and education
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
320
Inclusion Criteria

Not provided

Exclusion Criteria

1) History of laparotomy excluding laparoscopic cholecyctectomy and addendectomy (skin incision less than 5cm) 2) Non-curative factors proven by pre-operative examinations 3) Pre-operatiev chemotherapy 4) Synchronous malignancies other than carcinoma in situ of cervical cancer or focal cancer in adenoma of colorectal cancers 5) Metachronous malignancies within 5 years or with tumor recurrence 6) Severe respiratory dysfunction 7) History of myocardial infarction of two-step Master positive by ECG 8) Liver cirrhosis or chronic active hepatitis 9) Chronic renal failure with hemodialysis 10) Uncontrolled diabetes (HbA1C 9.0 or more) 11) Reflux esophagitis (LA grade A or more) 12) Other unfeasible factors to perform study safely, approved by attending surgeon

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
body weight loss rate at one year afer surgery
Secondary Outcome Measures
NameTimeMethod
incidence of delayed gastric empty, reflux esphagitis and surgical complication
© Copyright 2025. All Rights Reserved by MedPath